-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on SpyGlass Pharma, Raises Price Target to $43

Benzinga·11/12/2026 17:11:25
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains SpyGlass Pharma (NASDAQ:SGP) with a Buy and raises the price target from $37 to $43.